World's Best Scientists 2026 revealed!
Christoph Wanner

Christoph Wanner

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 123 3362 3136 181 174 828 54287

Christoph Wanner publications per year

The chart shows the history of publications by Christoph Wanner between 1983 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Christoph Wanner published across 43 years, from 1983 to 2025, averaging 25.2 papers a year. Output peaked at 84 publications in 2022. 90 of the 1,085 publications appeared in the last two years.

No. of publications
20 40 60 80
Bar chart. Horizontal axis: year, 1983 to 2025. Vertical axis: number of publications, 0 to 84. Peak 84 publications in 2022. 1983: 1 publication 1984: 0 publications 1985: 0 publications 1986: 2 publications 1987: 2 publications 1988: 1 publication 1989: 4 publications 1990: 1 publication 1991: 2 publications 1992: 6 publications 1993: 3 publications 1994: 6 publications 1995: 6 publications 1996: 8 publications 1997: 9 publications 1998: 8 publications 1999: 12 publications 2000: 9 publications 2001: 11 publications 2002: 16 publications 2003: 21 publications 2004: 7 publications 2005: 12 publications 2006: 24 publications 2007: 25 publications 2008: 27 publications 2009: 32 publications 2010: 28 publications 2011: 44 publications 2012: 28 publications 2013: 28 publications 2014: 42 publications 2015: 51 publications 2016: 56 publications 2017: 53 publications 2018: 64 publications 2019: 60 publications 2020: 65 publications 2021: 60 publications 2022: 84 publications 2023: 77 publications 2024: 49 publications 2025: 41 publications
1983 2025

1,085 publications in total across all disciplines

View publications per year as a table
Christoph Wanner: publications per year, 1983 to 2025
Year Publications
1983 1
1984 0
1985 0
1986 2
1987 2
1988 1
1989 4
1990 1
1991 2
1992 6
1993 3
1994 6
1995 6
1996 8
1997 9
1998 8
1999 12
2000 9
2001 11
2002 16
2003 21
2004 7
2005 12
2006 24
2007 25
2008 27
2009 32
2010 28
2011 44
2012 28
2013 28
2014 42
2015 51
2016 56
2017 53
2018 64
2019 60
2020 65
2021 60
2022 84
2023 77
2024 49
2025 41
Total 1,085
Download as CSV

Christoph Wanner publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Christoph Wanner sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 821–840 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 828 publications — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186 828
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Christoph Wanner D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Christoph Wanner sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 122–123 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 123 D-Index — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255 123
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Christoph Wanner is affiliated with the University of Würzburg in Germany. Their research primarily centers on the fields of Medicine with specific emphasis on Endocrinology, Diabetes and Metabolism, Nephrology, Cardiology and Cardiovascular Medicine, Surgery, and Molecular Biology.

Their work covers multiple main topics including Diabetes Treatment and Management, Chronic Kidney Disease and Diabetes, Dialysis and Renal Disease Management, Pancreatic Function and Diabetes, Diabetes Management and Research, Metabolism, Diabetes, and Cancer, as well as Blood Pressure and Hypertension Studies.

Wanner's recent notable publications include:

  • 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice (2021, European Heart Journal)
  • Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure (2020, New England Journal of Medicine)
  • 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension (2023, Journal of Hypertension)
  • Empagliflozin in Patients with Chronic Kidney Disease (2022, New England Journal of Medicine)
  • KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease (2022, Kidney International)

Frequent co-authors in Wanner's research include Bernard Zinman, Silvio E. Inzucchi, Kitty J. Jager, Christiane Drechsler, and Nicholas C Chesnaye.

Wanner has published extensively across a variety of scientific journals, with frequent contributions to:

  • Nephrology Dialysis Transplantation
  • Clinical Kidney Journal
  • Journal of the American Society of Nephrology
  • Kidney International
  • Circulation

Best Publications

  • The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

    Colin Baigent;Martin J Landray;Christina Reith;Jonathan Emberson

  • KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease

    Ian H. de Boer;M. Luiza Caramori;Juliana C.N. Chan;Hiddo J.L. Heerspink

  • Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials

    Jane Armitage;Colin Baigent;Elizabeth Barnes;D John Betteridge

  • Prevention and treatment of protein energy wasting in chronic kidney disease patients: a consensus statement by the International Society of Renal Nutrition and Metabolism

    T. Alp Ikizler;Noel J. Cano;Harold Franch;Denis Fouque

  • Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data

    G. Eiriksdottir;T. B. Harris;L. J. Launer;V. Gudnason

  • How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial

    Silvio E Inzucchi;Bernard Zinman;David Fitchett;Christoph Wanner

  • Long-Term Effects of Enzyme Replacement Therapy on Fabry Cardiomyopathy Evidence for a Better Outcome With Early Treatment

    Frank Weidemann;Markus Niemann;Frank Breunig;Sebastian Herrmann

  • Females with Fabry disease frequently have major organ involvement : Lessons from the Fabry Registry

    William R. Wilcox;William R. Wilcox;João Paulo Oliveira;Robert J. Hopkin;Alberto Ortiz

  • The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia.

    Jean-Charles Fruchart;Frank Sacks;Michel P Hermans;Gerd Assmann

  • CKD Prevalence Varies across the European General Population

    Katharina Brück;Vianda S. Stel;Giovanni Gambaro;Stein Hallan

  • Improvement of Cardiac Function During Enzyme Replacement Therapy in Patients With Fabry Disease A Prospective Strain Rate Imaging Study

    Frank Weidemann;Frank Breunig;Meinrad Beer;Joern Sandstede

  • Fabry disease: guidelines for the evaluation and management of multi-organ system involvement.

    Christine M Eng;Dominique P Germain;Maryam Banikazemi;David G Warnock

  • Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials

    Peter Willeit;Peter Willeit;Paul M Ridker;Paul J Nestel;John Simes

  • SGLT-2 inhibitors and cardiovascular risk: Proposed pathways and review of ongoing outcome trials

    Silvio E Inzucchi;Bernard Zinman;Christoph Wanner;Roberto Ferrari

  • Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease

    Christoph Wanner;John M. Lachin;Silvio E. Inzucchi;David Fitchett

  • KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patient.

    Christoph Wanner;Marcello Tonelli

  • Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe.

    Kitty J. Jager;Anneke Kramer;Nicholas C. Chesnaye;Cécile Couchoud

  • Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative

    B. Kasiske;F.G. Cosio;J. Beto;K. Bolton

  • Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trial

    David Z I Cherney;David Z I Cherney;Bernard Zinman;Silvio E Inzucchi;Audrey Koitka-Weber

  • Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

    Iain C. Macdougall;Andreas J. Bircher;Kai Uwe Eckardt;Gregorio T. Obrador

Frequent Co-Authors

Winfried März
Winfried März Medical University of Graz
Silvio E. Inzucchi
Silvio E. Inzucchi Yale University
Bernard Zinman
Bernard Zinman University of Toronto
David G. Warnock
David G. Warnock University of Alabama at Birmingham
Eberhard Ritz
Eberhard Ritz Heidelberg University
Friedo W. Dekker
Friedo W. Dekker Leiden University Medical Center
Kitty J. Jager
Kitty J. Jager University of Amsterdam
Kai-Uwe Eckardt
Kai-Uwe Eckardt Charité - University Medicine Berlin
Georg Ertl
Georg Ertl University of Würzburg
Alberto Ortiz
Alberto Ortiz Autonomous University of Madrid

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students exploring alternatives or specialized career tracks within medicine, accredited online degrees offer flexible routes to advance in the healthcare field. Many professionals are looking to accelerate their career progress through programs that can be completed efficiently and affordably.

For nurses aiming for leadership, a fastest dnp online program allows working professionals to earn their Doctor of Nursing Practice without interrupting their employment. Those concerned about tuition costs can also consider cheapest online dnp programs which make advanced nursing education more accessible.

Students seeking an earlier entry into patient care may benefit from lpn programs that offer streamlined pathways to become Licensed Practical Nurses in less time, often entirely online. Additionally, mental health professionals can broaden their expertise by choosing specialized routes such as psych np programs—ideal for those who wish to focus on psychiatric and mental health nursing.

Exploring these online degree options can help you find a program that matches your career ambitions, timeline, and budget.

Best Scientists Citing Christoph Wanner

Trending Scientists

Recently Published Articles